RELX PLC REL shares inched up 0.25% to £36.17 Tuesday, on what proved to be an all-around favorable trading session for the ...

MAGATs continually used this study to prove its efficacy even though many virologists disputed it. Digby wrote a great piece ...

A new die-attach process promises to cool power devices up to 15X more efficiently while reducing failure-inducing stresses ...

French study on hydroxychloroquine for COVID-19 retracted due to ethical concerns after global attention and FDA approval.

Perlego, an educational technology company dubbed the "Spotify for textbooks" wrapped up the most-read books by business ...

India launches the One Nation One Subscripotion (ONOS) scheme in January 2025, giving 1.8 crore students and faculty free ...

RELX PLC REL shares inched down 0.68% to £36.29 Friday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.26% to 8,084.61. Supported ...

A controversial study that presented hydroxychloroquine as a possible treatment for COVID-19 has been retracted from the ...

The medical knowledge of Renaissance artists, honed through the study of classical texts and direct anatomical exploration ...

The Science, Technology, Engineering, Mathematics and Innovation (STEMi) Makers of Africa has secured the Elsevier Mathematical Sciences Sponsorship Fund from Switzerland. Amanda Obidike, the ...

In this issue of The Lancet we feature 30 photographs selected from the many interesting images that were entered for this ...

The now-debunked research, endorsed by Donald Trump, led to millions of covid-19 patients receiving a worthless drug.